垂井病
WordNet
- an impairment of health or a condition of abnormal functioning
- caused by or altered by or manifesting disease or pathology; "diseased tonsils"; "a morbid growth"; "pathologic tissue"; "pathological bodily processes" (同)morbid, pathologic, pathological
PrepTutorEJDIC
- (体の)『病気』,疾患 / (精神・道徳などの)病気,病弊
- 女性の話術芸人 =diseur
- 病気にかかった / 病的な,不健全な(morbid)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
- Arikawa Y, Nishida H, Kurasawa O, Hasuoka A, Hirase K, Inatomi N, Hori Y, Matsukawa J, Imanishi A, Kondo M, Tarui N, Hamada T, Takagi T, Takeuchi T, Kajino M.SourcePharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., 26-1, Muraokahigashi-2-chome, Fujisawa, Kanagawa 251-8555, Japan. yasuyoshi.arikawa@takeda.com
- Journal of medicinal chemistry.J Med Chem.2012 May 10;55(9):4446-56. Epub 2012 Apr 30.
- In our pursuit of developing a novel and potent potassium-competitive acid blocker (P-CAB), we synthesized pyrrole derivatives focusing on compounds with low log D and high ligand-lipophilicity efficiency (LLE) values. Among the compounds synthesized, the compound 13e exhibited potent H(+),K(+)-AT
- PMID 22512618
Japanese Journal
- 低強度での持久性運動は心血管機能に変化を与えるか? : Wave Intensityを用いての検討
- 田中 みどり,泉 唯史,樽井 一郎,菅原 基晃
- 電子情報通信学会技術研究報告. MBE, MEとバイオサイバネティックス 108(270), 37-40, 2008-10-23
- 高齢者の心疾患患者が増加傾向にある昨今、運動療法を行う立場として低強度での持久性運動がもたらす生理学的特性を熟知しておくことは重要である。我々は心血管反応の鋭敏な指標であるwave Intensityを用いて低強度での持久性運動を施行した際の心血管反応を評価した。その結果20Wの低強度運動では中枢性の心血管指標に統計上優位な変化は現れなかった。20W強度での持久性運動は中枢性の心血管機能変化の少な …
- NAID 110007081878
Related Links
- Phosphofructokinase deficiency, also known as Glycogen storage disease type VII or Tarui's disease, is metabolic disorder ... It was named after the Japanese Physician, Seiichiro Tarui (1927- ), who was a native of Hyogo Prefecture in Japan.
- 16 Feb 2010 ... Tarui disease, also known as Glycogenosis type VII and Phosphofructokinase deficiency, is a rare disorder described in the database for rare diseases of the Swedish National Board of Health and Welfare.
Related Pictures
★リンクテーブル★
[★]
- 英
- Tarui disease
- 同
- VII型糖原病, 糖原病VII型, 糖原病7型, 7型糖原貯蔵障害, type VII glycogen storage disease, glycogen storage disease type VII, glycogenosis type VII
筋型ホスホフルクトキナーゼ欠損症 muscle phosphofructokinase deficiency、PFKM欠損症 PFKM deficiency phosphofructokinase, muscle type deficiency
- 関
- 糖原病
[★]
糖原病VII型、7型糖原貯蔵障害
- 関
- muscle phosphofructokinase deficiency、Tarui disease、type VII glycogen storage disease
[★]
筋ホスホフルクトキナーゼ欠損症
- 関
- glycogen storage disease type VII、Tarui disease
[★]
- 疾患:illnessより厳密な概念。「ある臓器に明確な障害が確認され、それによって症状が出ているとはっきり説明できる場合」 (PSY.9)
- 特定の原因、病態生理、症状、経過、予後、病理組織所見が全てそろった場合 (PSY.9)
- something that is very wrong with people's attitudes, way of life or with society.
- 関
- ail、ailment、disease entity、disorder、ill、illness、malady、sick、sickness
- disease ≠ illness ≠ disorder